Babagan Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor.
Source: Wikipedia
Kantor pusat251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Ngadeg2018
StatusAktif
Paten1 paten
GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERSEP2326310B1 · 2019
Ulasan
Durung ana ulasan. Wis kerja karo Assertio Therapeutics, Inc.? Dadi sing pisanan mbage pengalaman.
Informasi hukum
| Jeneng hukum | Assertio Therapeutics, Inc. |
|---|---|
| LEI | 549300L2A9NTF1JVDP20Deleng ing GLEIF ↗ |
| Alamat kadhaftar | 251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US |
| Status | Aktif |
Sumber: GLEIF · dianyari Oct. 16, 2026
Kontak & tautan
Lokasi
251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Apa iki perusahaan sampeyan?
Klaim kaca iki gratis kanggo nambah logo, produk, foto, lan kerja, lan kanggo mangsuli ulasan.
Klaim kaca ikiGabung Heelky kanggo nyambung, nyewa, lan tuwuh
Gawe akun gratis kanggo ngirim pesen, nglamar kerja, lan ngirim misi.
Gabung saiki — gratis